지투지바이오
42,100KRWMarket close of 10/21 (Wed)
Up +13.78%+5,100KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)41,200KRWDown -2.14%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 42,500
- High
- 45,000
- Low
- 41,400
- Day range
- Day range low 41,400 high 45,000, open 42,500, close 42,100, previous close 37,000
- Volume
- 115×10K shares
- 49.8B KRW 5.76× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
20%20% of the way up from the lowest close in 1 year (233 sessions) · -64.6% from the high
Something to check
2 to check: bigger daily move than usual · more trading value than usual
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto check+13.78%+13.78%, 2.7× the usual (20-session average ±5.09%)That day +13.78% · usual ±5.09% · large-move threshold ±10.2%
- Trading valueto check5.8×49.8B KRW, 5.8× the 20-session average5.76× the 20-session average · check threshold 3×
- Earningsnot verifiedOutside financial data coverage, so not verified
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional-300.00 million KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
| 한미약품 | Close over the last 20 sessions -26.3% | Up +0.26% | 28.1B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.